| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S0109 |
Methadone, oral, 5 mg |
55,872 |
11,346 |
$10.11M |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
18,695 |
3,402 |
$2.54M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
47,592 |
11,214 |
$945K |
| H0016 |
Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) |
9,593 |
7,097 |
$833K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
12,856 |
10,642 |
$624K |
| J3490 |
Unclassified drugs |
6,767 |
670 |
$393K |
| H0033 |
Oral medication administration, direct observation |
11,891 |
3,826 |
$263K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
17,282 |
12,747 |
$228K |
| H0001 |
Alcohol and/or drug assessment |
928 |
909 |
$143K |
| H0006 |
Alcohol and/or drug services; case management |
2,668 |
2,128 |
$54K |
| H0032 |
Mental health service plan development by non-physician |
144 |
144 |
$17K |
| 80305 |
|
1,280 |
947 |
$11K |
| G2067 |
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
8,543 |
2,065 |
$6K |
| 81025 |
|
774 |
481 |
$5K |
| 86580 |
|
455 |
430 |
$3K |
| 93000 |
|
251 |
240 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
58 |
54 |
$2K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
59 |
54 |
$2K |
| 84702 |
|
85 |
83 |
$766.03 |
| 98966 |
|
20 |
14 |
$179.13 |
| G2077 |
Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code |
711 |
450 |
$36.75 |
| G2078 |
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
1,929 |
557 |
$0.00 |
| G1028 |
Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
35 |
30 |
$0.00 |